BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
72.01
+0.29 (0.40%)
At close: Nov 28, 2025, 1:00 PM EST
72.49
+0.48 (0.67%)
After-hours: Nov 28, 2025, 4:51 PM EST
BridgeBio Pharma Market Cap
BridgeBio Pharma has a market cap or net worth of $13.88 billion as of November 28, 2025. Its market cap has increased by 198.24% in one year.
Market Cap
13.88B
Enterprise Value
15.09B
1-Year Change
198.24%
Ranking
Category
Stock Price
$72.01
Market Cap Chart
Since June 27, 2019, BridgeBio Pharma's market cap has increased from $3.32B to $13.88B, an increase of 318.01%. That is a compound annual growth rate of 24.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 13.88B | 167.59% |
| Dec 31, 2024 | 5.19B | -26.16% |
| Dec 29, 2023 | 7.02B | 516.56% |
| Dec 30, 2022 | 1.14B | -53.61% |
| Dec 31, 2021 | 2.46B | -71.83% |
| Dec 31, 2020 | 8.72B | 101.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 287.99B |
| Merck & Co. | 259.69B |
| Novartis AG | 249.49B |
| Abbott Laboratories | 223.51B |